Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast Cancer
Status:
Terminated
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of metronomic oral vinorelbine taken three times a week without
break plus bevacizumab as salvage treatment in patients with metastatic breast cancer.